CPC A61K 6/54 (2020.01) [A61K 6/69 (2020.01); A61K 6/80 (2020.01); A61K 31/4375 (2013.01); A61K 31/4439 (2013.01); A61K 31/451 (2013.01); A61K 31/4725 (2013.01); A61K 38/1825 (2013.01); A61K 38/193 (2013.01); A61K 38/195 (2013.01); A61K 38/4826 (2013.01); A61K 45/06 (2013.01); A61L 27/22 (2013.01); A61L 27/3633 (2013.01); A61L 27/54 (2013.01); A61P 1/02 (2018.01); C12Y 304/21004 (2013.01); A61L 2300/412 (2013.01); A61L 2300/414 (2013.01); A61L 2300/434 (2013.01); A61L 2300/436 (2013.01); A61L 2430/12 (2013.01)] | 12 Claims |
1. A non-cellular root canal filler comprising a tetrahydroisoquinoline compound, wherein the tetrahydroisoquinoline compound is selected from the group consisting of:
(+)-4-[[2-[6-fluoro-3-(4-fluorobenzyl)-3,4-dihydroisoquinolin-2 (1H-yl]ethylamino]methyl]-N-isopropylaniline monofumarate; and
(+)-N-[3-(methanesulfonylamino)benzyl]-2-[6-fluoro-3-(4-fluorobenzyl)-3,4-dihydroisoquinolin-2 (1H)-yl]ethanamine monocitrate.
|